The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN INC | COM | 00445A100 | 9,325,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 18,680,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 7,917,000 | 2,900,000 | SH | SOLE | 2,900,000 | 0 | 0 | ||
AMBRX BIOPHARMA INC | COM | 641871108 | 29,904,000 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 22,473,000 | 4,950,000 | SH | SOLE | 4,950,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 56,867,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 59,860,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
APPLIED THERAPEUTICS INC | COM | 03828A101 | 5,561,000 | 1,660,000 | SH | SOLE | 1,660,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 6,207,500 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 55,162,350 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,185,293 | 544,960 | SH | SOLE | 544,960 | 0 | 0 | ||
ATYR PHARMA INC | COM NEW | 002120202 | 8,248,500 | 5,850,000 | SH | SOLE | 5,850,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 7,013,750 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 4,375,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 135,671,250 | 1,625,000 | SH | SOLE | 1,625,000 | 0 | 0 | ||
DELCATH SYS INC | COM NEW | 24661P807 | 1,248,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 13,336,128 | 5,032,501 | SH | SOLE | 5,032,501 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 25,004,000 | 1,880,000 | SH | SOLE | 1,880,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 10,393,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 4,249,932 | 307,076 | SH | SOLE | 307,076 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 8,100,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | 4,728,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 64,044,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 631,776 | 421,184 | SH | SOLE | 421,184 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 27,328,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 50,556,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 19,000,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
INHIBRX INC | COM | 45720L107 | 3,800,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 928,395 | 493,827 | SH | SOLE | 493,827 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 8,130,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 28,485,900 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 2,631,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 9,058,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 5,776,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 9,900,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
MORPHOSYS AG | SPONSORED ADS | 617760202 | 14,602,500 | 1,475,000 | SH | SOLE | 1,475,000 | 0 | 0 | ||
NEUMORA THERAPEUTICS INC. | COM | 640979100 | 6,518,982 | 382,345 | SH | SOLE | 382,345 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 4,000 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 17,840,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 54,376,702 | 4,383,875 | SH | SOLE | 4,383,875 | 0 | 0 | ||
RAYZEBIO INC | COM | 75525N107 | 35,323,315 | 568,173 | SH | SOLE | 568,173 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 4,380,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 10,038,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 38,211,750 | 1,275,000 | SH | SOLE | 1,275,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 67,501,000 | 700,000 | SH | Call | SOLE | 700,000 | 0 | 0 | |
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 6,948,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 3,228,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 43,615,564 | 1,070,058 | SH | SOLE | 1,070,058 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 7,444,859 | 284,372 | SH | SOLE | 284,372 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 4,940,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 13,068,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,909,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 7,575,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 |